Learn About Osteosclerosis Autosomal Dominant
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
William White is a Family Medicine specialist and an Internal Medicine provider in Cordele, Georgia. Dr. White and is rated as an Advanced provider by MediFind in the treatment of Osteosclerosis Autosomal Dominant. His top areas of expertise are Childhood Pancreatitis, Cellulitis, Gastrointestinal Bleeding, Gastrostomy, and Colonoscopy. Dr. White is currently accepting new patients.
Southeast Medical Group, P.C.
Carlos Buchhammer is an Internal Medicine provider in Warner Robins, Georgia. Dr. Buchhammer and is rated as an Experienced provider by MediFind in the treatment of Osteosclerosis Autosomal Dominant. His top areas of expertise are Cirrhosis, Familial Combined Hyperlipidemia, Xanthoma, and Familial Hypertension. Dr. Buchhammer is currently accepting new patients.
Sugarloaf Medical Primary Care
Doctor Shukri George Makhlouf is trained in the Specialty of Internal Medicine Primary Care and is Board Certified by the American Board of Internal Medicine. He proudly serves not only as an Internal Medicine Physician but also as a Family Practice and Primary Care Doctor.He completed his Internal Medicine training at St. Mary’s Hospital – Affiliated hospital to Yale University School of Medicine. His internship and first year of residency were completed at the University of Medicine and Dentistry of New Jersey. Doctor Makhlouf is a member of the renowned American College of Physicians and American Academy of Family Practice Physicians. Hospital Affiliations are Gwinnet Medical Center in Duluth and Lawrenceville, Emory Johns Creek and Northside Forsyth in Cummings and Atlanta. Dr. Makhlouf is rated as an Experienced provider by MediFind in the treatment of Osteosclerosis Autosomal Dominant. His top areas of expertise are Enlarged Liver, Hypertensive Heart Disease, Type 2 Diabetes (T2D), and Galactocoele.
Summary: This single-institution, phase II study is designed to test the ability to achieve donor hematopoietic engraftment while maintaining low rates of transplant-related mortality (TRM) using busulfan- and fludarabine-based conditioning regimens with busulfan therapeutic drug monitoring (TDM) for patients with various inherited metabolic disorders (IMD) and severe osteopetrosis (OP).
Summary: The purpose of this study is to understand the course of rare genetic disorders that affect the brain. This data is being analyzed to gain a better understanding of the progression of the rare neurodegenerative disorders and the effects of interventions.